Shi L, Chen Y, Xie M, Chen Q, Qiao X, Cheng Q
J Immunother Cancer. 2025; 13(2).
PMID: 39915000
PMC: 11804199.
DOI: 10.1136/jitc-2024-010782.
Awan A, Osman M, Khan O
Cells. 2025; 14(2).
PMID: 39851497
PMC: 11763706.
DOI: 10.3390/cells14020069.
Gao C, Liu Y, Yu J, Wang R, Shi J, Chen R
Cells. 2025; 14(1.
PMID: 39791716
PMC: 11719737.
DOI: 10.3390/cells14010015.
Deng Y, Chen X, Chen X, Huang C, Zhang Z, Xu Z
BMC Cancer. 2024; 24(1):1158.
PMID: 39289660
PMC: 11409575.
DOI: 10.1186/s12885-024-12887-2.
Xu H, Zhang Y, Wang C, Fu Z, Lv J, Yang Y
Front Endocrinol (Lausanne). 2024; 15:1393111.
PMID: 38846492
PMC: 11153779.
DOI: 10.3389/fendo.2024.1393111.
Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties.
Prus G, Satpathy S, Weinert B, Narita T, Choudhary C
Cell. 2024; 187(11):2875-2892.e21.
PMID: 38626770
PMC: 11136510.
DOI: 10.1016/j.cell.2024.03.024.
Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis.
Cai F, Xu H, Song S, Wang G, Zhang Y, Qian J
Curr Protein Pept Sci. 2024; 25(7):577-585.
PMID: 38584528
DOI: 10.2174/0113892037287640240322084946.
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening.
Loh Y, Anantharajan J, Huang Q, Xu W, Fulwood J, Ng H
Protein Sci. 2024; 33(3):e4904.
PMID: 38358126
PMC: 10868430.
DOI: 10.1002/pro.4904.
Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1.
During J, Wolter M, Toplak J, Torres C, Dybkov O, Fokkens T
Nat Struct Mol Biol. 2024; 31(2):364-377.
PMID: 38332367
PMC: 10873202.
DOI: 10.1038/s41594-023-01203-4.
DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game.
Tayanloo-Beik A, Hamidpour S, Nikkhah A, Arjmand R, Mafi A, Rezaei-Tavirani M
Adv Exp Med Biol. 2023; 1470:165-188.
PMID: 37923882
DOI: 10.1007/5584_2023_791.
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells.
Maharati A, Moghbeli M
Cell Div. 2023; 18(1):11.
PMID: 37480054
PMC: 10362644.
DOI: 10.1186/s13008-023-00093-8.
Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy.
Vriend J
Cancers (Basel). 2023; 15(13).
PMID: 37444570
PMC: 10340382.
DOI: 10.3390/cancers15133460.
Axis and Differential Expression May Predict Pathogenesis and Poor Prognosis in De Novo Myelodysplastic Neoplasm.
de Carvalho L, Komoto T, Moreno D, Goes J, Germano de Oliveira R, de Lima Melo M
Int J Mol Sci. 2023; 24(12).
PMID: 37373211
PMC: 10298103.
DOI: 10.3390/ijms241210058.
Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review).
Lei X, Hu X, Lu Q, Fu W, Sun W, Ma Q
Oncol Rep. 2023; 49(3).
PMID: 36799184
PMC: 9944987.
DOI: 10.3892/or.2023.8500.
A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature.
Ji D, Liu Y, Sun W, Shi Q, Chen G, Song Z
Aging (Albany NY). 2022; 14(24):9951-9968.
PMID: 36534449
PMC: 9831738.
DOI: 10.18632/aging.204432.
Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K, Ling X, Jiang X, Ma J, Zhu J
Respir Res. 2022; 23(1):306.
PMID: 36357897
PMC: 9650835.
DOI: 10.1186/s12931-022-02226-z.
UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress.
Dutta R, Guruvaiah P, Reddi K, Bugide S, Bandi D, Edwards Y
NAR Cancer. 2022; 4(4):zcac035.
PMID: 36338541
PMC: 9629447.
DOI: 10.1093/narcan/zcac035.
Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.
Vriend J, Thanasupawat T, Sinha N, Klonisch T
Int J Mol Sci. 2022; 23(20).
PMID: 36293188
PMC: 9604155.
DOI: 10.3390/ijms232012330.
Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.
Fiesco-Roa M, Teresa B, Leal-Anaya P, van T Hek R, Wegman-Ostrosky T, Frias S
Front Oncol. 2022; 12:949435.
PMID: 36091172
PMC: 9453478.
DOI: 10.3389/fonc.2022.949435.
The DNA-damage kinase ATR activates the FANCD2-FANCI clamp by priming it for ubiquitination.
Sijacki T, Alcon P, Chen Z, McLaughlin S, Shakeel S, Rappsilber J
Nat Struct Mol Biol. 2022; 29(9):881-890.
PMID: 36050501
PMC: 7613635.
DOI: 10.1038/s41594-022-00820-9.